QIST Collaborative - Arthroplasty Research Cohort (ARC) Study

Sponsor
Northumbria Healthcare NHS Foundation Trust (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05824845
Collaborator
University of York (Other)
5,000
96

Study Details

Study Description

Brief Summary

The ARC Study is a national observational cohort study to investigate patient reported and clinical outcomes after hip and knee replacements. The study has the following objectives:

  1. To evaluate outcomes following hip and knee replacements.

  2. To determine risk factors for adverse outcomes in primary hip and knee replacements.

  3. To identify targets for future research and intervention in patients undergoing primary hip and knee replacements

  4. To provide a resource from which to identify potential participants for future clinical trials, and to use data collected in the ARC Study as comparison or control data for trial participants who have been randomised to receive one or more interventions.

Participants are recruited and consented online. Patients are invited to participate by collaborating surgical teams nationally in outpatient clinics at the time of being added to a waiting list, in addition to an advertising campaign to recruit patients. They are directed to an online portal where they will be able to review further information.

Consent and data collection is completed electronically through patients entering data online. Baseline demographics and characteristics are recorded, including details of socio-demographics, lifestyle, health status and patient reported outcome measures (PROMs). Patients then undergo hip/knee replacement and postoperative rehabilitation according to the standard care and protocols of the hospital and the preferences of their treating surgeon.

Follow-up data, including PROMs, is collected via online questionnaires up to two years following surgery. The study will ultimately also enable multiple trials to be embedded within the cohort study, using a 'Trials within Cohorts' (TwiCs) methodology.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Hip/Knee Replacement

Study Design

Study Type:
Observational
Anticipated Enrollment :
5000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
QIST Collaborative - Arthroplasty Research Cohort (ARC) Study - A Collaborative, Longitudinal Observational Cohort Study of Patients Undergoing Primary Hip and Knee Replacements in the United Kingdom
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
May 1, 2030
Anticipated Study Completion Date :
May 1, 2031

Arms and Interventions

Arm Intervention/Treatment
ARC Study Cohort

Procedure: Hip/Knee Replacement
Hip/Knee Replacement

Outcome Measures

Primary Outcome Measures

  1. EQ-5D-5L health-related quality of life score [2 years]

Secondary Outcome Measures

  1. PROMIS-10 [2 years]

    Patient-Reported Outcomes Measurement Information System Global Health

  2. Oxford Hip Score [2 years]

  3. Oxford Knee Score [2 years]

  4. Musculoskeletal Health Questionnaire [2 years]

    MSK-HQ

  5. Hospital for Special Surgery Hip/Knee Replacement Expectations Surveys [2 years]

    Perception of success/fulfilment of expectations

  6. Patient Health Questionnaire-4 [2 years]

    PHQ-4

  7. 11-point Numerical Pain Rating Scale [2 years]

    Pain

  8. Pain Catastrophising Scale [2 years]

  9. Length of stay [2 years]

    Self-reported by study specific electronic questionnaire

  10. Activity [2 years]

    Levels of exercise and activity self-reported by study specific electronic questionnaire

  11. Return to work [2 years]

    Work status self-reported by electronic questionnaire using National Statistics Socio-economic Classification

  12. Readmission within 30 days [30 days]

  13. Surgical Site Infection [2 years]

  14. Periprosthetic Fracture [2 years]

  15. Dislocation [2 years]

  16. Revision/Re-operation [2 years]

  17. Mortality [2 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Participants must meet all of the inclusion criteria:
  1. UK Resident

  2. Able to read and understand documentation and questionnaires in English language

  3. Undergoing elective primary hip or knee arthroplasty (THR, TKR or UKR)

  4. Age 18 years or over

  5. Provides the necessary consents relating to data collection and use of study data, data linkage, future research and invitation to involvement in future trials

Exclusion Criteria:

Provided a participant meets all of the inclusion criteria, there are no exclusion criteria for the cohort study.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Northumbria Healthcare NHS Foundation Trust
  • University of York

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Northumbria Healthcare NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT05824845
Other Study ID Numbers:
  • ARC Study
First Posted:
Apr 24, 2023
Last Update Posted:
Apr 24, 2023
Last Verified:
Apr 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Northumbria Healthcare NHS Foundation Trust
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 24, 2023